XEL
67
2
IP
70
2
HRL
39
15
V
60
-6
MA
55
-7
SWK
56
-2
GM
65
-3
NWSA
62
2
VRSN
53
3
F
43
-8
DVN
16
3
BEN
45
3
MAS
51
4
LUV
39
-5
EQIX
60
-2
CL
56
5
DHI
48
3
IBM
54
4
IR
63
3
JPM
63
-4
XEL
67
2
IP
70
2
HRL
39
15
V
60
-6
MA
55
-7
SWK
56
-2
GM
65
-3
NWSA
62
2
VRSN
53
3
F
43
-8
DVN
16
3
BEN
45
3
MAS
51
4
LUV
39
-5
EQIX
60
-2
CL
56
5
DHI
48
3
IBM
54
4
IR
63
3
JPM
63
-4
Financhill
Back

OncoCyte Vs. ProPhase Labs Industry Stock Comparison

Sell
43

OCX
OncoCyte

Last Price:
2.65
Seasonality Move:
36.67%
Sell
18

PRPH
ProPhase Labs

Last Price:
0.77
Seasonality Move:
14.29%
Sell
43
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy, Sell or Hold?

  • The current OncoCyte [OCX] share price is $2.75. The Score for OCX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • OCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy, Sell or Hold?

  • The current ProPhase Labs [PRPH] share price is $0.77. The Score for PRPH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

OCX Stock Price Chart

What is OncoCyte's stock price today?

  • The OncoCyte share price today is $2.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRPH Stock Price Chart

What is ProPhase Labs's stock price today?

  • The ProPhase Labs share price today is $0.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing buying pressure, which is a positive indicator for future bullish movement.

OCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 42.67 Sell
Chaikin Money Flow: 19918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.77 - 3.11) Sell
Bollinger Bands (100): (2.91 - 3.21) Sell

PRPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 18.52 Sell
Chaikin Money Flow: 35835 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.97 - 2.43) Sell
Bollinger Bands (100): (1.8 - 3.18) Sell

OCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.77 Sell
20-day SMA: 2.89 Sell
50-day SMA: 2.99 Sell
200-day SMA: 2.95 Sell
8-day EMA: 2.74 Buy
20-day EMA: 2.85 Sell
50-day EMA: 2.95 Sell
200-day EMA: 3.21 Sell

PRPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.76 Buy
20-day SMA: 1.53 Sell
50-day SMA: 2.05 Sell
200-day SMA: 3.85 Sell
8-day EMA: 0.89 Sell
20-day EMA: 1.34 Sell
50-day EMA: 1.92 Sell
200-day EMA: 3.44 Sell

OncoCyte Earnings Growth & OCX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.

ProPhase Labs Earnings Growth & PRPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):